Export

ATC codes: L01CA02
EMLc
Indication
Hodgkin lymphoma ICD11 code: 2C10.Z
INN
Vincristine
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate) ; 5 mg in vial (vincristine sulfate)
EML status history
First added in 2015 (TRS 994)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for vincristine on the complementary list of the EML and EMLc for use in treatment protocols for Hodgkin lymphoma was specifically endorsed. The relevant extracts from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for Hodgkin lymphoma in adults and in paediatrics are attached.